AMELIA MASSON: Open Payments
NPI 1376284935 · COVINGTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$675 in 7 payments from 7 companies in 2025. Trend: 2023 $459 · 2024 $910 · 2025 $675
Food & beverage: $675
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 1 | $139 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $118 |
| Phathom Pharmaceuticals, Inc. | 1 | $115 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $97 |
| Exact Sciences Corporation | 1 | $97 |
| Novo Nordisk Inc | 1 | $90 |
| Philips North America LLC | 1 | $18 |
Products named: LEQVIO, XIFAXAN, VOQUEZNA, Kerendia, The Cologuard Plus Collection Kit, Wegovy, Vest Therapy Und.
Industry payments across LA — which companies pay providers there.
